Thor Ueland

28.2k total citations · 1 hit paper
563 papers, 19.4k citations indexed

About

Thor Ueland is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thor Ueland has authored 563 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Molecular Biology, 134 papers in Immunology and 128 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thor Ueland's work include Tryptophan and brain disorders (47 papers), Cardiac Fibrosis and Remodeling (44 papers) and Bone Metabolism and Diseases (42 papers). Thor Ueland is often cited by papers focused on Tryptophan and brain disorders (47 papers), Cardiac Fibrosis and Remodeling (44 papers) and Bone Metabolism and Diseases (42 papers). Thor Ueland collaborates with scholars based in Norway, United States and Sweden. Thor Ueland's co-authors include Pål Aukrust, Lars Gullestad, Pål Aukrust, Arne Yndestad, Stig S. Frøland, Jens Bollerslev, Jan Kristian Damås, Bente Halvorsen, Kristin Godang and Erik Øie and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Thor Ueland

551 papers receiving 19.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial

2016 288 citations Ola Kleveland, Thor Ueland et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thor Ueland	5.6k	4.8k	4.0k	3.1k	2.7k	563	19.4k
Pål Aukrust	5.2k 0.9×	4.5k 0.9×	5.2k 1.3×	2.5k 0.8×	3.4k 1.3×	479	18.7k
Peter P. Nawroth	9.8k 1.7×	2.7k 0.6×	6.5k 1.6×	3.6k 1.2×	4.0k 1.5×	494	36.3k
Holger K. Eltzschig	7.9k 1.4×	2.9k 0.6×	4.4k 1.1×	4.2k 1.4×	2.3k 0.9×	290	27.3k
Angelika Bierhaus	6.2k 1.1×	1.8k 0.4×	4.5k 1.1×	1.5k 0.5×	2.4k 0.9×	247	22.7k
Fabrizio Montecucco	3.5k 0.6×	2.9k 0.6×	3.0k 0.7×	2.3k 0.7×	2.3k 0.9×	403	13.1k
Ronald L. Wilder	3.8k 0.7×	1.4k 0.3×	5.9k 1.5×	1.9k 0.6×	1.5k 0.6×	113	27.1k
Ann Rumley	1.8k 0.3×	6.0k 1.3×	2.1k 0.5×	3.4k 1.1×	5.7k 2.1×	209	19.0k
Mark B. Pepys	1.8k 0.3×	3.1k 0.6×	2.4k 0.6×	3.1k 1.0×	5.4k 2.0×	27	13.9k
Peter Pickkers	2.9k 0.5×	1.8k 0.4×	4.2k 1.0×	2.4k 0.8×	4.6k 1.7×	443	18.8k
Giamila Fantuzzi	7.0k 1.2×	1.2k 0.3×	6.5k 1.6×	1.9k 0.6×	5.6k 2.1×	198	19.6k

Countries citing papers authored by Thor Ueland

Since Specialization

Citations

This map shows the geographic impact of Thor Ueland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thor Ueland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thor Ueland more than expected).

Fields of papers citing papers by Thor Ueland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thor Ueland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thor Ueland. The network helps show where Thor Ueland may publish in the future.

Co-authorship network of co-authors of Thor Ueland

This figure shows the co-authorship network connecting the top 25 collaborators of Thor Ueland. A scholar is included among the top collaborators of Thor Ueland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thor Ueland. Thor Ueland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nilsen, Dennis W, Thor Ueland, Pål Aukrust, et al.. (2025). Sex-related differences in the prognostic utility of inflammatory and thrombotic cardiovascular risk markers in patients with chest pain of suspected coronary origin. IJC Heart & Vasculature. 56. 101600–101600. 1 indexed citations

Barratt‐Due, Andreas, Jan Cato Holter, Anne Ma Dyrhol‐Riise, et al.. (2024). Escalated complement activation during hospitalization is associated with higher risk of 60‐day mortality in SARS‐CoV‐2‐infected patients. Journal of Internal Medicine. 296(1). 80–92. 4 indexed citations

Aukrust, Pål, et al.. (2024). Galectin-3-binding protein and future venous thromboembolism. Research and Practice in Thrombosis and Haemostasis. 8(1). 102311–102311. 2 indexed citations

Woxholt, Sindre, Thor Ueland, Pål Aukrust, et al.. (2024). Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI. International Journal of Cardiology. 418. 132613–132613. 1 indexed citations

Bredholt, Geir, Marianne Sævik, Hanne Søyland, et al.. (2024). Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults. Vaccine X. 20. 100564–100564. 3 indexed citations

Retterstøl, Kjetil, Ingunn Narverud, Martin P. Bogsrud, et al.. (2024). Adherence to the Healthy Nordic Food Index is associated with reduced plasma levels of inflammatory markers in patients with heterozygous familial hypercholesterolemia. SHILAP Revista de lepidopterología. 58. 38–45. 2 indexed citations

Szabó, Attila, Kevin S. O’Connell, Ibrahim A. Akkouh, et al.. (2024). Elevated levels of peripheral and central nervous system immune markers reflect innate immune dysregulation in autism spectrum disorder. Psychiatry Research. 342. 116245–116245. 3 indexed citations

Ueland, Thor, et al.. (2023). Plasma levels of P-selectin and future risk of incident venous thromboembolism. Journal of Thrombosis and Haemostasis. 21(9). 2451–2460. 5 indexed citations

Åsberg, Anders, Thor Ueland, Anna Varberg Reisæter, et al.. (2023). Systemic inflammation early after kidney transplantation is associated with long-term graft loss: a cohort study. Frontiers in Immunology. 14. 1253991–1253991. 6 indexed citations

10.

Latysheva, Nadezhda, Annika E. Michelsen, Thor Ueland, et al.. (2023). Complement factors B, D, C3bBbP and risk of future venous thromboembolism. Clinical Immunology. 249. 109278–109278. 2 indexed citations

11.

Parker, Nadine, Weiqiu Cheng, Guy Hindley, et al.. (2023). Genetic Overlap Between Global Cortical Brain Structure, C-Reactive Protein, and White Blood Cell Counts. Biological Psychiatry. 95(1). 62–71. 10 indexed citations

12.

Ueland, Thor, et al.. (2023). Fatty Acids Composition and HIV Infection: Altered Levels of n-6 Polyunsaturated Fatty Acids Are Associated with Disease Progression. Viruses. 15(7). 1613–1613. 4 indexed citations

13.

Sikkeland, Liv Ingunn Bjoner, Thor Ueland, May Brit Lund, Michael T. Durheim, & Tom Eirik Mollnes. (2023). A role for the terminal C5-C9 complement pathway in idiopathic pulmonary fibrosis. Frontiers in Medicine. 10. 1236495–1236495. 8 indexed citations

14.

Ueland, Thor, Pål Aukrust, Annika E. Michelsen, et al.. (2017). Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipients. Open Heart. 4(2). e000635–e000635. 16 indexed citations

15.

Ueland, Thor, Ståle H. Nymo, Roberto Latini, et al.. (2013). CCL21 is Associated with Fatal Outcomes in Chronic Heart Failure: Data from CORONA and GISSI-HF Trials. European Journal of Heart Failure. 15(7). 747–755. 15 indexed citations

16.

Broch, Kaspar, Thor Ueland, Ståle H. Nymo, et al.. (2012). Soluble ST2 is Associated with Adverse Outcome in Patients with Heart Failure of Ischaemic Aetiology. European Journal of Heart Failure. 14(3). 268–277. 106 indexed citations

17.

Latini, Roberto, Lars Gullestad, Serge Masson, et al.. (2012). Pentraxin-3 in Chronic Heart Failure: The CORONA and GISSI-HF Trials. European Journal of Heart Failure. 14(9). 992–999. 80 indexed citations

18.

Solberg, Ole Geir, Thor Ueland, Ragnhild Wergeland, et al.. (2012). High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis. Scandinavian Cardiovascular Journal. 46(5). 278–285. 23 indexed citations

19.

Jansson, Anna, Pål Aukrust, Thor Ueland, et al.. (2009). Soluble CXCL16 Predicts Long-Term Mortality in Acute Coronary Syndromes. Circulation. 119(25). 3181–3188. 44 indexed citations

20.

Yndestad, Arne, Leif Erik Vinge, Reidar Bjørnerheim, et al.. (2006). Thalidomide Attenuates the Development of Fibrosis During Post-Infarction Myocardial Remodelling in Rats. European Journal of Heart Failure. 8(8). 790–796. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact